Surgery with Islet Autotransplantation for Patients with Pancreatic Cancer
Official title: Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation (IAtx) in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (POPF)
Run by Technische Universität Dresden · NCT05843877 · Data updated 2026-11-12
This study is testing if a surgery that includes removing the whole pancreas and transplanting the patient's own insulin-producing cells can help people with pancreatic cancer avoid complications and start treatment faster compared to just removing part of the pancreas.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Technische Universität Dresden Academic / other |
| Locations | 1 site (Dresden) |
| Status | Recruiting |
| Started | January 28, 2025 |
| Main results expected | January 2028 |
| Study ends | January 2028 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT05843877 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with suspected or confirmed periampullary carcinoma who are at high risk for postoperative pancreatic fistula.
✕Probably not a fit
Patients with other primary tumors, those requiring additional simultaneous procedures, or those with certain infections or diabetes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of total pancreatectomy combined with islet autotransplantation compared to pancreatic head resection alone in patients with periampullary cancer who are at high risk for developing postoperative pancreatic fistulas. The study aims to reduce perioperative complications and expedite the start of adjuvant therapy. Participants will undergo either a classic Whipple procedure or pylorus-preserving pancreaticoduodenectomy, followed by the transplantation of their own pancreatic islets. The trial focuses on patients with specific anatomical and health profiles that increase their risk for complications.
Why it matters
Potential benefit: If successful, this approach could significantly reduce complications and improve recovery times for patients undergoing surgery for periampullary cancer.
How similar studies have gone: While similar approaches have been explored, this specific combination of total pancreatectomy with islet autotransplantation in this patient population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * suspected or confirmed periampullary carcinoma (tumor) and indication for PPPD (pylorus-preserving pancreaticoduodenectomy) or Whipple surgery * high-risk profile for the development of a postoperative pancreatic fistula (POPF) after pancreatic head resection: soft pancreas and Pancreatic duct diameter \< 3 mm (preoperative and intraoperative confirmation) * written informed consent of the participant after successful Informed consent Exclusion Criteria: * patients on whom another procedure is to be performed simultaneously in addition to PPPD or Whipple surgery * confirmed other primary tumor * previous transplantation of an organ or tissue * known infection with HIV (HIV antibodies) * positive hepatitis C antibodies, positive hepatitis B surface antigens and hepatitis Bc antibodies * insulin-treated diabetes mellitus * history of hypersensitivity to any of the drugs used or their ingredients or to drugs with a similar chemical structure * concurrent participation in another clinical trial (incl. within the last 4 weeks prior to inclusion). * addiction or other medical conditions that do not allow the subject to understand the nature and not be able to appreciate the nature, scope and possible consequences of the trial * pregnant or breastfeeding women * women of childbearing age, except for women who meet the following criteria: 1. Post-menopausal (12 months of natural amenorrhea or 6 months of amenorrhea with Serum FSH \> 40 U/ml) 2. Post-operative (6 weeks after bilateral ovariectomy with or without hysterectomy) 3. Regular and correct use of a contraceptive method with an failure rate \< 1% per year 4. Sexual abstinence 5. Vasectomy of the partner * evidence that the patient is unlikely to comply with the protocol
Where it's running
-
University Hospital Carl Gustav Carus Technische Universität Dresden
Dresden, Germany Recruiting
Study contacts
- Principal investigator: Barbara Ludwig, Prof. Dr. — Department of internal Medicine III
- Study coordinator: Barbara Ludwig, Prof. Dr.
- Email: barbara.ludwig@ukdd.de
- Phone: +49 458
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tissue-glue injection into the pancreas during pancreaticoduodenectomy
This trial will test whether injecting a tissue glue called N-butyl-2-cyanoacrylate into the pancreatic remnant during pancreaticoduodenectomy reduces postoperative pancreatic fistulas in patients with a soft pancreas and a small main duct.
-
Saleh's technique: injecting Histoacryl glue into the pancreas during pancreaticojejunostomy
This procedure will try injecting a tissue glue (Histoacryl) into the pancreas during pancreaticoduodenectomy to see if it reduces pancreatic leaks in people with a soft pancreas and a small pancreatic duct.
-
Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life
This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.
-
Tissue adhesive (Glubran®2) to reinforce pancreaticojejunostomy in soft pancreas
This trial will test whether adding a tissue adhesive glue (Glubran®2) to the pancreatic-jejunal connection reduces postoperative pancreatic leaks in adults with a soft pancreas undergoing pancreaticoduodenectomy.
-
Neoadjuvant chemotherapy versus immediate surgery for resectable pancreatic head and periampullary cancer
This trial tests if giving chemotherapy before surgery helps people with resectable pancreatic head or periampullary cancer live longer than having immediate surgery followed by chemotherapy.
-
Predicting pancreatic fistula after pancreaticoduodenectomy
This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.